Quick Takeaways
- Seven Fleet Partners LP filed SCHEDULE 13G for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
- Disclosed ownership: 0.2%.
- Date of event: 13 May 2025.
Seven Fleet Partners LP - 13 May 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)
- Filing Manager
- Seven Fleet Partners LP
- Reporting Manager
- Seven Fleet Partners LP
- Symbol
- CTMX
- Disclosed Ownership
- 377,161 shares
- Ownership
- 0.2%
- Form type
- SCHEDULE 13G
- Filing time
- 20 May 2025, 21:02:04 UTC
- Date of event
- 13 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Seven Fleet Partners LP disclosed 0.2% ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX) on 13 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 May 2025, 21:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Seven Fleet Partners LP | 0.2% | 377,161 | 0 | 377,161 | /s/ Brian Liu | Brian Liu, Managing Member of Seven Fleet Advisors, LLC, its Investment Manager | |
| Seven Fleet Advisors LLC | 0.2% | 377,161 | 0 | 377,161 | /s/ Brian Liu | Brian Liu, Managing Member | |
| Brian Liu | 0.2% | 377,161 | 0 | 377,161 | /s/ Brian Liu | Brian Liu |